NCT06703125Recruiting
The Alama Project: Autism Outcomes and Neurobehavioral Markers in Young Children Born to Mothers With HIV in Kenya
Source: ClinicalTrials.gov · Last updated 26 May 2026
Brief summary (registry, in English)
The study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series of eye-tracking measures to determine whether these can predict autism diagnoses in both children exposed to HIV and uninfected (CHEU) and children not exposed to HIV and uninfected (CHUU).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 850 (estimated)
- First submitted
- 21 Nov 2024
- Start date
- 11 Feb 2025
- Primary completion date
- 28 Feb 2029
- Lead sponsor
- Indiana University
- NCT number
- NCT06703125
What you commit to
- Study type: Interventional
- Planned participants: 850
- From 11 Feb 2025 to the primary completion date, 28 Feb 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- There will be no specific exclusion criteria. We anticipate that a small number of CHEU and CHUU will develop HIV prior to enrollment in the current study; these children will be included and will follow all general study procedures.
Who the study is looking for
- Children enrolled in the Tabiri study (R01HD104552)
- CHEU or CHUU
- Children ages 24-72 months
- Caregivers of children must speak Kiswahili (local language) or English.
Age in the registry: 24 months to 72 months · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Moi Teaching and Referral Hospital Coordinator of this site? Confirm its status | Eldoret | Kenya | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.